Utility of Gene Test Analysis for Diagnosis, Prognosis and Treatment of Patients With Genetic Arrhythmic Heart Disease: the ARRHYTHMIC GENE-HEART
Launched by UNIVERSITY HOSPITAL OF FERRARA · Mar 26, 2025
Trial Information
Current as of April 29, 2025
Recruiting
Keywords
ClinConnect Summary
The ARRHYTHMIC GENE-HEART trial is studying how gene tests can help diagnose and treat patients with genetic heart diseases that cause abnormal heart rhythms, known as arrhythmias. This research is happening at the Cardiogenetic Center in Ferrara, Italy, where they aim to gather detailed information about patients who are suspected of having these conditions. By collecting data on patients' health, family history, and treatment outcomes, the study hopes to improve our understanding of these genetic issues and how they affect patients over time.
To be eligible for this study, participants should be patients who have been evaluated at the Cardiogenetic Center and have a confirmed genetic heart disease. If someone decides to join, they can expect to provide information about their health and family history, and they will be monitored over time to see how their condition progresses and how well different treatments work. It’s important to note that patients who do not have a genetic heart condition or who refuse to give consent will not be able to participate in this trial.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients evaluated at the Cardiogenetic Center of the University of Ferrara in Ferrara, Italy.
- • Having a proven cardiogenetic disease
- Exclusion Criteria:
- • Refuse to provide informed consents
- • Patients not having a cardiogenic disease
About University Hospital Of Ferrara
The University Hospital of Ferrara, a leading academic medical institution in Italy, is dedicated to advancing healthcare through innovative research and clinical excellence. Affiliated with the University of Ferrara, the hospital is known for its commitment to integrating cutting-edge scientific inquiry with patient care. With a multidisciplinary approach, the institution conducts a wide range of clinical trials aimed at enhancing treatment methodologies and improving patient outcomes in various medical fields. The University Hospital of Ferrara prioritizes ethical standards and patient safety, fostering a collaborative environment that engages researchers, healthcare professionals, and patients in the pursuit of medical advancement.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ferrara, , Italy
Patients applied
Trial Officials
Cristina Balla, MD PhD
Principal Investigator
Università degli Studi di Ferrara
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported